COVID–19 Vaccine Developers Gold Medal Act

Senate Bill 2011 - COVID–19 Vaccine Developers Gold Medal Act: Overview, Status, and Impact

Hozzl · 2022-12-31T05:28:52Z

Explore the details of Senate Bill 2011 COVID–19 Vaccine Developers Gold Medal Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/31/2022, 5:28 AM

Congressional Summary of S 2011

COVID-19 Vaccine Developers Gold Medal Act

This bill provides for the award of a Congressional Gold Medal to recognize all those whose efforts led to the development of COVID-19 vaccines that received emergency use authorizations.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2011

Bill S 2011 is currently in the status of Bill Introduced since June 10, 2021. Bill S 2011 was introduced during Congress 117 and was introduced to the Senate on June 10, 2021. Bill S 2011's most recent activity was Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. as of June 10, 2021

Bipartisan Support of Bill S 2011

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2011

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health

- Congressional tributes

- Emergency medical services and trauma care

- Health technology, devices, supplies

- Immunology and vaccination

- Infectious and parasitic diseases

- Museums, exhibitions, cultural centers

- Science and engineering education

- Smithsonian Institution

Alternate Title(s) of Bill S 2011

A bill to award a Congressional Gold Medal to honor the contributions of all those whose efforts led to the successful development of life saving vaccines to combat the novel coronavirus.

COVID–19 Vaccine Developers Gold Medal Act